Aspira Women's Health Announces Transition Of Its Chief Scientific Officer/Chief Operating Officer; Ryan Phan, Ph.D. Stepping Down Effective September 15, 2023
Portfolio Pulse from Benzinga Newsdesk
Aspira Women's Health Inc. (NASDAQ:AWH) announced that its Chief Scientific and Operating Officer, Ryan Phan, Ph.D., will step down effective September 15, 2023. However, Dr. Phan will remain as an advisor for the company, providing scientific and operational advice related to ongoing product development programs. The company is confident in its ability to launch EndoCheck before the end of 2023.
August 09, 2023 | 9:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ryan Phan, the Chief Scientific and Operating Officer of Aspira Women's Health, is stepping down but will remain as an advisor. This could potentially impact the company's operations and product development.
The departure of a key executive like the Chief Scientific and Operating Officer could potentially disrupt the company's operations and product development. However, since Dr. Phan will remain as an advisor, the impact might be mitigated. The company's confidence in launching EndoCheck before the end of 2023 also suggests that the transition might be smooth.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100